1025 related articles for article (PubMed ID: 11329059)
21. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
[TBL] [Abstract][Full Text] [Related]
22. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis.
Tjwa M; Luttun A; Autiero M; Carmeliet P
Cell Tissue Res; 2003 Oct; 314(1):5-14. PubMed ID: 13680354
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
24. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
[TBL] [Abstract][Full Text] [Related]
25. The discovery of the placental growth factor and its role in angiogenesis: a historical review.
Ribatti D
Angiogenesis; 2008; 11(3):215-21. PubMed ID: 18568405
[TBL] [Abstract][Full Text] [Related]
26. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.
Shih SC; Ju M; Liu N; Smith LE
J Clin Invest; 2003 Jul; 112(1):50-7. PubMed ID: 12840058
[TBL] [Abstract][Full Text] [Related]
27. 15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression.
Viita H; Markkanen J; Eriksson E; Nurminen M; Kinnunen K; Babu M; Heikura T; Turpeinen S; Laidinen S; Takalo T; Ylä-Herttuala S
Circ Res; 2008 Feb; 102(2):177-84. PubMed ID: 17991885
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of placenta growth factor/vascular endothelial growth factor synergy in endothelial hydraulic conductivity and proliferation.
Dull RO; Yuan J; Chang YS; Tarbell J; Jain RK; Munn LL
Microvasc Res; 2001 Mar; 61(2):203-10. PubMed ID: 11254400
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
30. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
[TBL] [Abstract][Full Text] [Related]
31. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
32. PlGF blockade does not inhibit angiogenesis during primary tumor growth.
Bais C; Wu X; Yao J; Yang S; Crawford Y; McCutcheon K; Tan C; Kolumam G; Vernes JM; Eastham-Anderson J; Haughney P; Kowanetz M; Hagenbeek T; Kasman I; Reslan HB; Ross J; Van Bruggen N; Carano RA; Meng YJ; Hongo JA; Stephan JP; Shibuya M; Ferrara N
Cell; 2010 Apr; 141(1):166-77. PubMed ID: 20371352
[TBL] [Abstract][Full Text] [Related]
33. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.
Hiratsuka S; Maru Y; Okada A; Seiki M; Noda T; Shibuya M
Cancer Res; 2001 Feb; 61(3):1207-13. PubMed ID: 11221852
[TBL] [Abstract][Full Text] [Related]
34. Effects of angiogenic growth factor combinations on retinal endothelial cells.
Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
[TBL] [Abstract][Full Text] [Related]
35. Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.
Hedlund EM; Yang X; Zhang Y; Yang Y; Shibuya M; Zhong W; Sun B; Liu Y; Hosaka K; Cao Y
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):654-9. PubMed ID: 23267058
[TBL] [Abstract][Full Text] [Related]
36. The placenta growth factor in skin angiogenesis.
Odorisio T; Cianfarani F; Failla CM; Zambruno G
J Dermatol Sci; 2006 Jan; 41(1):11-9. PubMed ID: 16216466
[TBL] [Abstract][Full Text] [Related]
37. A critical role of placental growth factor in the induction of inflammation and edema formation.
Oura H; Bertoncini J; Velasco P; Brown LF; Carmeliet P; Detmar M
Blood; 2003 Jan; 101(2):560-7. PubMed ID: 12393422
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factors and angiogenesis in eye disease.
Witmer AN; Vrensen GF; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2003 Jan; 22(1):1-29. PubMed ID: 12597922
[TBL] [Abstract][Full Text] [Related]
39. Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression.
Feeney SA; Simpson DA; Gardiner TA; Boyle C; Jamison P; Stitt AW
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):839-47. PubMed ID: 12556420
[TBL] [Abstract][Full Text] [Related]
40. Structure and function of placental growth factor.
De Falco S; Gigante B; Persico MG
Trends Cardiovasc Med; 2002 Aug; 12(6):241-6. PubMed ID: 12242046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
